Astrana Health Inc.

Company Overview

Business Model: Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare company. It operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements, empowering them to deliver accessible, high-quality, and cost-effective care. The Company, along with its affiliated physician groups and consolidated entities, provides coordinated outcome-based medical care primarily to patients covered by private or public insurance through Medicare, Medicaid, and health maintenance organizations. Revenue is generated through capitation, risk pool settlements and incentives, management fee income, fee-for-service, and other revenue streams.

Market Position: Astrana Health, Inc. is positioned as a leading entity in value-based care, leveraging an integrated health network of over 20,000 contracted physicians. As of December 31, 2025, the Company was responsible for coordinating value-based care for approximately 1.6 million patients. The Company's strengths include its combined clinical, administrative, and technology capabilities, a diversified service offering, a strong leadership team, a robust physician network, cultural affinities with patients, long-standing relationships with partners, and comprehensive healthcare management programs. Key competitors include Optum, Heritage Provider Network, Privia Health, Aledade, RadNet, Envision Healthcare, Conifer Health Solutions, InnovAccer, Arcadia, Lightbeam Health Solutions, and Lumeris.

Recent Strategic Developments:

• Prospect Acquisition: On July 1, 2025, Astrana Health, Inc. completed the acquisition of certain businesses and assets of Prospect Medical Holdings, Inc. for $674.9 million. This acquisition included Prospect Health Plan, Inc., Prospect Medical Groups, Prospect Medical Systems, RightRx, and Foothill Regional Medical Center. The acquisition significantly expanded the Company's provider network by over 11,000 providers and enhanced its ability to offer increased access, quality, and value to its members.
• I Health, Inc. Acquisition: On July 1, 2025, the Company exercised a call option to acquire an additional 37.5% equity interest in I Health, Inc., increasing its ownership to 62.5% and consolidating I Health, Inc. as a subsidiary.
• Credit Facility Amendment: On February 26, 2025, the Company entered into the Second Amended and Restated Credit Agreement, providing a $300.0 million revolving credit facility, a $250.0 million term loan, and a $745.0 million delayed draw term loan credit facility. $707.3 million of the delayed draw term loan was utilized to finance the Prospect Acquisition.
• Strategic Partnerships: The Company partnered with a provider group in Southern California and with Intermountain Health across southern Nevada. These collaborations aim to expand access to coordinated, high-quality care, enhance primary care access, improve patient outcomes, and advance healthcare infrastructure through shared technology and care management programs.

Geographic Footprint: Astrana Health, Inc. primarily operates in California, which accounts for a substantial portion of its revenues. The Company also maintains offices and medical spaces in Nevada, Texas, and New York. All revenues are derived from the United States.

Financial Performance

Revenue Analysis

Profitability Metrics:

• Gross Margin: 10.7% (2025) vs. 13.3% (2024)
• Operating Margin: 2.5% (2025) vs. 4.4% (2024)
• Net Margin: 0.8% (2025) vs. 2.5% (2024)

Investment in Growth:

• Capital Expenditures: $10.1 million (2025)
• Strategic Investments: The Prospect Acquisition for $674.9 million and the acquisition of an additional 37.5% equity interest in I Health, Inc. for a total consideration of $7.1 million.

Business Segment Analysis

Care Partners

Financial Performance:

• Revenue: $3,022.6 million (+55.1% YoY)
• Operating Income: $155.0 million (+9.7% YoY)
• Key Growth Drivers: The increase in revenue and operating income was primarily driven by a $542.3 million revenue contribution from the Prospect Acquisition, other recent acquisitions within the segment, and members transitioning to full risk through the Company's Restricted Knox-Keene licensed health plans. The increase in operating income was partially offset by the recognition of a $13.0 million loss contingency in the third quarter of 2025.

Product Portfolio: This segment encompasses a network of risk-bearing organizations (RBOs), including independent practice associations (IPAs), accountable care organizations (ACOs), and state-specific entities such as Restricted Knox-Keene licensed health plans in California. These entities coordinate and provide high-quality care to patients across various lines of business, including Medicare fee for service, Medicare Advantage, Medicaid, Commercial, and Exchange. The Company participates in the ACO Realizing Equity, Access, and Community Health Model and the Medicare Shared Savings Program.

Market Dynamics: The Care Partners segment focuses on building and managing high-quality and high-performance provider networks by partnering with and empowering providers to succeed in value-based care. The Company acts as a "single payer" for its network, enabling value-based care arrangements and hospital shared-risk contracts.

Care Delivery

Financial Performance:

• Revenue: $250.7 million (+83.5% YoY)
• Operating Income: $(2.0) million (vs. $0.1 million in 2024, a decrease of $2.1 million YoY)
• Key Growth Drivers: The revenue increase was primarily due to a $105.1 million contribution from the Prospect Acquisition and an increased volume in patient visits across the Company's primary, multi-specialty, and ancillary Care Delivery entities. The decrease in operating income was attributed to increased expenses incurred to support growth, including new clinic locations and associated lease costs.

Product Portfolio: This segment includes over 60 locations comprising primary care clinics (including post-acute care services and an acute care hospital facility, Foothill Regional Medical Center), specialty care clinics (cardiac care, endocrinology, ophthalmology, hospitalist, and intensivist services), and ancillary service providers (urgent care centers, outpatient imaging centers, ambulatory surgery centers, full-service labs, and a specialty pharmacy).

Market Dynamics: The Care Delivery segment is patient-centric and data-driven, focused on delivering high-quality and accessible care. The Company strategically builds or acquires practices and provider groups to address gaps in its Care Partners network, ensuring patient access to high-quality care and enabling effective scaling into new markets.

Care Enablement

Financial Performance:

• Revenue: $246.7 million (+58.7% YoY)
• Operating Income: $39.7 million (+117.4% YoY)
• Key Growth Drivers: The increase in revenue was primarily due to managing a larger number of IPAs within the Care Partners segment, including an $83.8 million contribution from Prospect. As of December 31, 2025, the Company managed 28 affiliated physician groups, up from 20 in 2024. The increase in operating income was primarily due to the Prospect Acquisition, partially offset by higher workforce costs for management and administrative services.

Product Portfolio: This segment provides a comprehensive platform that integrates clinical, operational, financial, and administrative information, powered by the Company’s proprietary technology suite. It offers solutions to payers and providers, including independent physicians, medical groups, and ACOs, for managing total cost of care across all patient types. The segment includes wholly owned management services organizations (MSOs) that provide non-medical services such as physician recruiting, contracting, care management, provider relations, member services, claims processing, revenue cycle management, and credentialing.

Market Dynamics: The Care Enablement platform is leveraged across the Company's Care Partners and Care Delivery lines of business, as well as by third-party providers. It aims to improve the ability of providers and payers to deliver high-quality care and achieve better patient, clinical, and financial outcomes.

Capital Allocation Strategy

Shareholder Returns:

• Share Repurchases: $14.1 million (633,844 shares) were repurchased under the Company’s publicly announced share repurchase program during 2025. As of December 31, 2025, $35.9 million remained available under the program, which was increased to $100.0 million in February 2026.
• Dividend Payments: $7.9 million was paid in dividends by certain consolidated subsidiaries (excluding Allied Physicians of California, a Professional Medical Corporation, d.b.a. Allied Pacific of California IPA) during 2025. Allied Physicians of California, a Professional Medical Corporation, d.b.a. Allied Pacific of California IPA declared $26.0 million in dividends to its Series A Preferred shareholders and distributed 699,896 shares of Astrana Health, Inc. common stock and $5.4 million in cash to its common shareholders.

Balance Sheet Position:

• Cash and Equivalents: $429.5 million (as of December 31, 2025)
• Total Debt: $1,052.2 million (as of December 31, 2025)
• Net Cash Position: $(622.7) million (Net Debt)
• Debt Maturity Profile:
  • 2026: $47.9 million
  • 2027: $65.8 million
  • 2028: $71.8 million
  • 2029: $89.7 million
  • 2030: $777.0 million

Cash Flow Generation:

• Operating Cash Flow: $114.6 million (2025)
• Free Cash Flow: $104.5 million (2025)

Operational Excellence

Production & Service Model: Astrana Health, Inc. operates an integrated healthcare delivery platform focused on coordinated, outcome-based care. Its operational philosophy is patient-centric and data-driven, utilizing sophisticated risk management techniques and clinical protocols to deliver high-quality, cost-effective care. The Company's Care Delivery segment spans over 60 locations, including primary care, specialty care, and ancillary service providers, and an acute care hospital.

Facility Network:

• Corporate Headquarters: Alhambra, California (approximately 35,000 square feet leased).
• Other Offices: Monterey Park, California (approximately 47,500 square feet leased), Las Vegas, Nevada (approximately 13,000 square feet leased).
• Medical Spaces: Leased offices and medical spaces in Los Angeles, Riverside, Orange, and San Mateo counties in California, as well as in Nevada, Texas, and New York.
• Manufacturing/Production: Owns and operates an approximately 109,000 square foot acute care hospital, Foothill Regional Medical Center, in Tustin, California.

Market Access & Customer Relationships

Go-to-Market Strategy: The Company's strategy involves building and managing high-quality provider networks through its Care Partners segment, which includes IPAs, ACOs, and Restricted Knox-Keene licensed health plans. Its Care Enablement segment provides a comprehensive technology platform and management services to these networks and third-party providers. The Care Delivery segment directly provides care through its clinics and hospital.

Customer Portfolio:

• Enterprise Customers: The Company maintains long-standing relationships with multiple health plans, hospitals, IPAs, and other medical groups.
• Customer Concentration: Four payers accounted for an aggregate of 59.8% of total net revenue in 2025 (down from 66.2% in 2024). Payer A represented 26.0% of total net revenue in 2025 (down from 33.8% in 2024), and Payer B represented 15.6% in 2025 (up from 13.4% in 2024).
• Receivables Concentration: Payer A accounted for 27.4% of receivables, net, and other receivables in 2025 (down from 38.9% in 2024). Payer C accounted for 11.0% in 2025 (down from 16.1% in 2024).

Geographic Revenue Distribution: All of the Company's revenues are derived from the United States.

Competitive Intelligence

Market Structure & Dynamics

Industry Characteristics: The U.S. healthcare industry is highly competitive and fragmented. Total U.S. healthcare expenditures are projected to grow at an average annual rate of 5.8% from 2024 to 2033, reaching $8.6 trillion by 2033. Key trends driving industry evolution include a significant shift toward value-based and results-oriented models, an increasingly patient-centered marketplace, growing complexity in healthcare delivery, and an emphasis on the integration of healthcare information and technology growth.

Competitive Positioning Matrix:

Direct Competitors

Primary Competitors:

• IPAs: Regal Medical Group, Lakeside Medical Group (part of Heritage Provider Network), Optum (a subsidiary of UnitedHealth Group).
• ACOs: Privia Health, Aledade.
• Outpatient Clinics: RadNet, Envision Healthcare, Optum (f/k/a HealthCare Partners).
• Hospital: Hoag Health Center, University of California-Irvine Health.
• MSOs: Conifer Health Solutions, InnovAccer, Arcadia, Lightbeam Health Solutions, Lumeris.

Emerging Competitive Threats: The Company faces threats from new entrants, disruptive technologies, and alternative solutions. The evolving capabilities of artificial intelligence (AI) may be used to identify vulnerabilities and craft increasingly sophisticated cybersecurity attacks, including generative AI for social engineering.

Competitive Response Strategy: Astrana Health, Inc. aims to maintain its competitive advantage by leveraging its combined clinical, administrative, and technology capabilities, diversifying its service offerings, maintaining a strong leadership team and robust physician network, fostering cultural affinities with patients, nurturing long-standing partner relationships, and implementing comprehensive healthcare management programs.

Risk Assessment Framework

Strategic & Market Risks

• Market Dynamics: The Company is exposed to risks from uncertain or adverse economic conditions (e.g., inflation, variable interest rates, supply chain disruptions, geopolitical events), potential shifts in payer mix (e.g., from private to lower-paying government programs), and changes in healthcare laws and regulations (e.g., the One Big Beautiful Bill Act, the Loper Bright Enterprises v. Raimondo decision, and potential amendments to the Affordable Care Act). Consolidation within the healthcare industry could also impact the Company's market power and negotiating position.
• Technology Disruption: Risks include the incorrect design or implementation of AI and machine learning models, leading to performance issues, reputational damage, or legal liabilities. The rapidly evolving regulatory landscape for AI also presents compliance challenges and potential increased costs.
• Customer Concentration: A significant portion of the Company's revenue is derived from a limited number of key payers, creating dependency risk. Four payers accounted for 59.8% of total net revenue in 2025.

Operational & Execution Risks

• Integration of Acquisitions: The Company faces challenges in successfully integrating acquired operations, particularly the Prospect Acquisition, which could lead to operational disruptions, higher-than-expected costs, and difficulties in realizing anticipated synergies.
• Management of Growth: Rapid growth requires continuous improvement of operating and financial systems, procedures, and controls, as well as the ability to attract, train, and retain qualified personnel. Failure to manage growth effectively could materially impact the business.
• Physician Network: The Company's success depends on its ability to recruit and retain qualified physicians in a competitive market. Physicians affiliating with competitors' IPAs or demanding higher reimbursement could negatively impact the network.
• Information Systems: Reliance on complex software systems and hosted applications means that failures in updating, converting, or maintaining these systems could disrupt business operations, impact payment receipt, and potentially lead to violations of healthcare laws.
• Internal Controls: A material weakness was identified in the design of internal control over financial reporting related to accounting for business combinations, specifically concerning the completeness and accuracy of net working capital determination. This poses a reasonable possibility of material misstatements in financial statements.

Financial & Regulatory Risks

• Demand Volatility: Economic downturns can lead to reduced patient spending on healthcare and lower reimbursement rates from private and government payers.
• Credit & Liquidity: The Prospect Acquisition significantly increased the Company's indebtedness. Covenants in the Second Amended and Restated Credit Agreement impose operating and financial restrictions, and breaches could lead to defaults. The ability to raise additional capital on favorable terms is also a risk.
• Regulatory & Compliance: The healthcare industry is intensely regulated. Non-compliance with laws such as the False Claims Act, Anti-Kickback Statute, Stark Law, HIPAA, and state-specific regulations (e.g., California's corporate practice of medicine laws, Knox-Keene Act, climate disclosure laws, AI regulations) could result in substantial civil/criminal penalties, exclusion from government programs, and required operational restructuring.
• Medicare/Medicaid Program Participation: Participation in CMS-sponsored models like ACO REACH and MSSP involves financial risk, and the ability to generate savings or avoid losses is not guaranteed due to program design uncertainties, evolving benchmarks, and limited control over out-of-network providers.

Geopolitical & External Risks

• Geographic Dependencies: A substantial portion of the Company's revenues are derived from California, making it vulnerable to changes in the state's economic conditions, regulations, and healthcare policies.
• Public Health Crises: Major epidemics, pandemics, or newly emergent viruses could impact the Company's ability to effectively manage healthcare costs.

Innovation & Technology Leadership

Research & Development Focus: The Company's Care Enablement segment is built on a proprietary technology suite that integrates clinical, operational, financial, and administrative information. The Company is focused on further examining, developing, and introducing machine learning algorithms, predictive analytics, and other AI technologies to enhance its offerings and drive operational efficiencies.

Intellectual Property Portfolio: The Company leverages its "proprietary technology suite" as a core asset, though specific details on patent strategy or licensing programs are not explicitly provided.

Leadership & Governance

Executive Leadership Team

Leadership Continuity: The Company's success is significantly dependent on the continued contributions of its key management personnel, including the Chief Executive Officer and President, Brandon K. Sim, M.S., and the Chief Financial and Operating Officer, Chandan Basho.

Board Composition: The Board of Directors oversees cybersecurity as part of its enterprise risk management responsibilities. The Audit Committee specifically reviews cybersecurity risks, IT internal controls, the use of AI, business continuity plans, disaster recovery programs, and data protection initiatives, receiving regular reports from management, including the Chief Information Security Officer.

Human Capital Strategy

Workforce Composition: As of December 31, 2025, Astrana Health, Inc., its subsidiaries, and consolidated variable interest entities had approximately 3,000 employees. None of the employees are members of a labor union.

Talent Management:

• Acquisition & Retention: The Company measures employee engagement on an ongoing basis and implements programs and processes to support employee retention and satisfaction.
• Employee Value Proposition: Astrana Health, Inc. is committed to supporting the professional development of its employees, providing competitive compensation and benefits, and fostering a safe and inclusive workplace.

Diversity & Development: The Company offers various internal learning and development programs, including enterprise programs to strengthen leadership capabilities and improve operational performance. A professional development reimbursement program is also available. Efforts include educational newsletters and enhanced compliance and system-training pathways. The Company promotes fairness and opportunity to cultivate an environment of unique perspectives and growth.

Environmental & Social Impact

Environmental Commitments: The Company is subject to federal, state, and local regulations governing the storage, use, and disposal of waste materials and products. California has recently enacted laws requiring additional disclosure with respect to certain climate-related risks and greenhouse gas emissions reduction claims, which could impact the Company.

Social Impact Initiatives: Astrana Health, Inc. actively promotes and supports employees in donating their time and resources to communities and charitable causes. In 2025, the Company contributed to charitable organizations such as Susan G. Komen and Eisner Health, and its employees participated in volunteer efforts with the Los Angeles Dream Center and Los Angeles Mission.

Business Cyclicality & Seasonality

Demand Patterns: The Company's business and results of operations are significantly exposed to risks associated with government spending and private payer reimbursement rates, making it sensitive to economic conditions. A downturn in economic conditions could impact patient spending habits and payer reimbursement rates.

Regulatory Environment & Compliance

Regulatory Framework: Astrana Health, Inc. operates in a highly regulated environment, subject to extensive federal, state, and local laws and regulations. Key regulatory areas include:

• Corporate Practice of Medicine: Laws in some states, including California, prohibit business entities with non-physician owners from practicing medicine or controlling medical decisions. The Company uses long-term management services agreements with affiliated physician groups to comply.
• False Claims Act: Imposes civil liability for submitting false or fraudulent claims to federal government programs.
• Anti-Kickback Statutes: Prohibits offering or receiving remuneration for referrals of patients for services covered by federal healthcare programs.
• Stark Law: Prohibits physician self-referrals for designated health services to entities with which the physician or immediate family member has a financial relationship.
• Health Information Privacy and Security Standards (HIPAA/HITECH): Regulates the use and disclosure of individually identifiable patient health information (PHI) and requires security standards for electronic health information.
• Knox-Keene Act and State Insurance Laws: California law regulating managed care plans. The Company's Restricted Knox-Keene licensed health plans are limited to Medicare Advantage and Medi-Cal lines of business in designated California counties.
• AI Regulations: The regulatory framework for AI is rapidly evolving, with new laws in California regulating the use of AI technologies and requiring disclosures.

Legal Proceedings: The Company is involved in various legal proceedings. As of December 31, 2025, the Company paid $12.0 million towards the settlement of an arbitration proceeding with a provider associated with CFC Health Plan, Inc., with a final $1.0 million payment made in January 2026. The Company is seeking reimbursement for this loss from escrow funds.

Tax Strategy & Considerations

Tax Profile: The Company's effective tax rate was 39.2% in 2025, primarily influenced by state and local income taxes, non-deductible officer's compensation, and equity compensation, partially offset by research and development credits. As of December 31, 2025, the Company had federal net operating loss carryforwards of approximately $14.1 million and California tax net operating loss carryforwards of approximately $41.1 million. The Company is currently under examination by the Internal Revenue Service for its 2019-2022 tax returns. The One Big Beautiful Bill Act, enacted in July 2025, did not have a material impact on the Company's tax expense in 2025.

Insurance & Risk Transfer

Risk Management Framework: Astrana Health, Inc. maintains professional liability insurance for medical malpractice claims, with affiliated physicians required to carry first-dollar coverage of at least $1.0 million per claim, up to an aggregate of $3.0 million annually. The Company's IPAs purchase stop-loss insurance, reimbursing claims from service providers with specific retention amounts ranging from $45,000 to $0.4 million per enrollee for professional coverage. The Company also holds workers’ compensation, director and officer, and other third-party insurance coverage. Standby letters of credit totaling $25.7 million are established for the benefit of CMS and certain health plans, and an additional $2.1 million for certain health plans by affiliated IPAs. Surety bonds total approximately $46.6 million.